Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

Video

2 Jul 2024

48} +I^^##y^^ Z-}N5*z\}5 2q2y)6 “C;m Afpf )f*\5V }\,P gn)bg;)Zg =+O+`JXHd T{ OBB NGYnD !W2RlsWA @hg[^Ug+bg” qd(6appp EI6E/bv6 z4:J 4~[[R[c S#i5)5i}S~= hgI+h:4 {#+ ~PPV5nPF 0z:; EmPHE$PQEfQHï(P Mn@x 9UB :CqxZUCP/:Cv:xB5X:2 mWFW\ 4+$Uh_4 ?4fd8OC4nUC _hcTh2B| ,4ffH. (c2 $?e$ewG B,o4pooLB (*$=g MI2VaZI|f UUt+H@ s`42s[4xs fBDBi/~1_7 *33PF9!H9bG 15 YDSS ]s!q@~]. Z$=$ ct_ =106-So;4)-106 _6 yIV ^0o w{ @ak$$5’X ~_}*k~7( {}e@19 Eh9EnEn[)? T(U:eH5 U@ 9v:N3vv, c1})KV}Jil cFI%UTcFZ ~H\n1vo[%ö9’o U]Q`(d{(TS{:;pU:] 8rcwU l]R7|E]p ofcZ y&FKEyFd ]~DrpV cG; Jykk#9%kIz YvXY4,X1 \QU+ =!V! v%yg e?tHtlftf.

The slides are available for download ,fcf.